General Information
Theracos DM2 C-450
A multi-center, randomized, double-blind, placebo-controlled, parallel group study to compare the efficacy and safety of bexagliflozin to placebo in subjects with type 2 diabetes mellitus and inadequate glycemic control
| Protocol | THR-1442-C-450 |
|---|---|
| Identifier | Site No: 1068 |
| UID | 0241e572-1c13-43e5-8cbc-e89992037326 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2016 |
| NCT Number | - |
| Created | 2016-02-10 10:33 |
| Last Updated | 2016-02-10 10:33 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2016-10-12 | No |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2016-03-31 | No |
| PI Meeting Start | 2016-03-17 | No |
| PI Meeting End | 2016-03-18 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2017-05-01 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Theracos Sub, LLC |
|---|---|
| Division | Theracos Sub, LLC |
| Team | Theracos Sub, LLC |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Topstone Research |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
